Advances in pharmacological treatment of type 1 diabetes during pregnancy

References

• Guerin A, Nisenbaum R, Ray JG. Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes. Diabetes Care. 2007;30:1920–1925.
   PubMed Web of Science ®Google Scholar
• Pearson DW. The relationship between pre-pregnancy care and early pregnancy loss, major congenital anomaly or perinatal death in type I diabetes mellitus. BJOG. 2007;114:104–107.
   PubMed Web of Science ®Google Scholar
• Jensen DM, Korsholm L, Ovesen P, et al. Peri-conceptionalA1Candrisk of serious adverse pregnancy outcome in 933 women with type 1 diabetes. Diabetes Care. 2009;32:1046–1048.
   PubMed Web of Science ®Google Scholar
• Galindo A, Burguillo AG, Azriel S, et al. Outcome of fetuses in women with pregestational diabetes mellitus. J Perinat Med. 2006;34:323–331.
   PubMed Web of Science ®Google Scholar
• Greene MF, Hare JWCJP, Benacerraf BR, et al. First trimester hemoglobinA1 and risk for major malformation and spontaneous abortion in diabetic pregnancy. Teratology. 1989;39:225–231.
   PubMedGoogle Scholar
• Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ. 2004;328:915.
   PubMed Web of Science ®Google Scholar
• Cohen AL, Wenger JB, James-Todd T, et al. The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes. Hypertens Pregnancy. 2014;33:81–92.
   PubMed Web of Science ®Google Scholar
• Jensen DM, Damm P, Moelsted-Pedersen L, et al. Outcomes in type1 diabetic pregnancies: a nationwide, population-based study. Diabetes Care. 2004;27:2819–2823.
   PubMed Web of Science ®Google Scholar
• Casson IF. Pregnancy in women with diabetes–after the CEMACH report, what now? Diabet Med. 2006;23:481–484.
   PubMed Web of Science ®Google Scholar
• Kitzmiller JL, Block JM, Brown FM, et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care. 2008;31:1060–1079.
   PubMed Web of Science ®Google Scholar
• Crowther CA, Alsweiler JM, Hughes R, et al. Tight or less tight glycaemic targets for women with gestational diabetes mellitus for reducing maternal and perinatal morbidity? (TARGET): study protocol for a stepped wedge randomised trial. BMC Pregnancy Childbirth. 2018;18:425.
   PubMed Web of Science ®Google Scholar
• Patti AM, Giglio RV, Pafili K, et al. Pharmacotherapy for gestational diabetes. Expert Opin Pharmacother. 2018;19:1407–1414.
   PubMed Web of Science ®Google Scholar
• de Valk HW, Visser GH. Insulin during pregnancy, labour and delivery. Best Pract Res Clin Obstet Gynaecol. 2011;25:65–76.
   PubMed Web of Science ®Google Scholar
• Gunton JE, Morris J, Boyce S, et al. Outcome of pregnancy complicated by pre-gestational diabetes–improvement in outcomes. Aust N Z J Obstet Gynaecol. 2002;42:478–481.
   PubMed Web of Science ®Google Scholar
• ACOG Committee on Practice Bulletins. ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 60, March 2005. Pregestational diabetes mellitus. Obstet Gynecol. 2005;105:675–685.
   PubMedGoogle Scholar
• Blumer I, Hadar E, Hadden DR, et al. Diabetes and pregnancy: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2013;98:4227–4249.
   PubMed Web of Science ®Google Scholar
• O’Sullivan JB, Mahan CM. Criteria for the oral glucose tolerance test in pregnancy. Diabetes. 1964;13:278–285.
   PubMed Web of Science ®Google Scholar
• Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144:768–773.
   PubMed Web of Science ®Google Scholar
• National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039–1057.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. American diabetes association workshop-conference on gestational diabetes: summary and recommendations. Diabetes Care. 1980;3:499–501.
   PubMed Web of Science ®Google Scholar
• Metzger BE. Summary and recommendations of the third international workshop-conference on gestational diabetes mellitus. Diabetes. 1991;40:197–201.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Diabetes mellitus: report of a WHO study group. Italy: Geneva; Technical Report Series 727 [ cited 2019 Feb 20]. Available from: https://apps.who.int/iris/bitstream/handle/10665/39592/WHO_TRS_727.pdf;jsessionid=8D6809271B529F1FBA91BFF378268B93?sequence=1
   Google Scholar
• Metzger BE, Lowe LP, HAPO Study Cooperative Research Group, et al., Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991–2002.
   PubMed Web of Science ®Google Scholar
• International Association of Diabetes & Pregnancy Study Groups (IADPSG) Consensus Panel Writing Group and the Hyperglycemia & Adverse Pregnancy Outcome (HAPO) Study Steering Committee, Metzger BE, Gabbe SG, et al., The diagnosis of gestational diabetes mellitus: new paradigms or status quo? J Matern Fetal Neonatal Med. 2012;25:2564–2569.
   Google Scholar
• Werner EF, Pettker CM, Zuckerwise L, et al. Screening for gestational diabetes mellitus: are the criteria proposed by the international association of the diabetes and pregnancy study groups cost-effective? Diabetes Care. 2012;35:529–535.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Glycemic targets: standards of medical care in diabetes-2018. Diabetes Care. 2018;41:55–64.
   PubMed Web of Science ®Google Scholar
• Duran A, Sáenz S, Torrejón MJ, et al. Introduction of IADPSG criteria for the screening and diagnosis of gestational diabetes mellitus results in improved pregnancy outcomes at a lower cost in a large cohort of pregnant women: the St. Carlos gestational diabetes study. Diabetes Care. 2014;37:2442–2450.
   PubMed Web of Science ®Google Scholar
• Feig DS, Donovan LE, Corcoy R, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet. 2017;390:2347–2359.
   PubMed Web of Science ®Google Scholar
• Stewart ZA, Wilinska ME, Hartnell S, et al. Day-and-Night closed-loop insulin delivery in a broad population of pregnant women with type 1 diabetes: A randomized controlled crossover trial. Diabetes Care. 2018;41:1391–1399.
   PubMed Web of Science ®Google Scholar
• Rigla M, Martínez-Sarriegui I, García-Sáez G, et al. Gestational diabetes management using smart mobile telemedicine. J Diabetes Sci Technol. 2018;12:260–264.
   PubMedGoogle Scholar
• Lapolla A, Dalfrà MG, Spezia R, et al. Outcome of pregnancy in type 1 diabetic patients treated with insulin lispro or regular insulin: an Italian experience. Acta Diabetol. 2008;45:61–66.
   PubMed Web of Science ®Google Scholar
• Mathiesen ER, Kinsley B, Amiel SA, et al. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care. 2007;30:771–776.
   PubMed Web of Science ®Google Scholar
• O’Neill SM, Kenny LC, Khashan AS, et al. Different insulin types and regimens for pregnant women with pre-existing diabetes. Cochrane Database Syst Rev. 2017;2:CD011880.
   PubMed Web of Science ®Google Scholar
• Mathiesen ER, Hod M, Ivanisevic M, et al. Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes. Diabetes Care. 2012;35:2012–2017.
   PubMed Web of Science ®Google Scholar
• García-Patterson A, Gich I, Amini SB, et al. Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction. Diabetologia. 2010;53:446–451.
   PubMed Web of Science ®Google Scholar
• McManus RM, Ryan EA. Insulin requirements in insulin-dependent and insulin-requiring GDM women during final month of pregnancy. Diabetes Care. 1992;15:1323–1327.
   PubMed Web of Science ®Google Scholar
• Callesen NF, Ringholm L, Stage E, et al. Insulin requirements in type 1 diabetic pregnancy: do twin pregnant women require twice as much insulin as singleton pregnant women? Diabetes Care. 2012;35:1246–1248.
   PubMed Web of Science ®Google Scholar
• Garrison EA, Jagasia S. Inpatient management of women with gestational and pregestational diabetes in pregnancy. Curr Diab Rep. 2014;14:457.
   PubMed Web of Science ®Google Scholar
• Jovanovic L, Peterson CM. Insulin and glucose requirements during the first stage of labor in insulin-dependent diabetic women. Am J Med. 1983;75:607–612.
   PubMed Web of Science ®Google Scholar
• Dalfrà MG, Burlina S, Sartore G, et al. Ketoacidosis in diabetic pregnancy. J Matern Fetal Neonatal Med. 2016;29:2889–2895.
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Women’s and Children’s Health. Diabetes in pregnancy: management from preconception to the postnatal period. London: National Institute for Health and Care Excellenece (NICE); 2015.
   Google Scholar
• AMD-SID-SIEDP interassociatory group. Keto diabetic acidosis: consent document. Italy: Turin; 2015 cited 2015 Sep 19. Available from http://www.siedp.it/files/1_Lachetoacidosidiabetica29_09_15.pdf
   Google Scholar
• Jovanovic L. Glucose and insulin requirements during labor and delivery: the case for normoglycemia in pregnancies complicated by diabetes. Endocr Pract. 2004;10:40–45.
   PubMedGoogle Scholar
• Riviello C, Mello G, Jovanovic LG. Breastfeeding and the basal insulin requirement in type 1 diabetic women. Endocr Pract. 2009;15:187–193.
   PubMed Web of Science ®Google Scholar
• Gouveri E, Papanas N, Hatzitolios AI, et al. Breastfeeding and diabetes. Curr Diabetes Rev. 2011;7:135–142.
   PubMedGoogle Scholar
• Cnattingius S, Bergström R, Lipworth L, et al. Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med. 1998;338:147–152.
   PubMed Web of Science ®Google Scholar
• Chung JH, Melsop KA, Gilbert WM, et al. Increasing pre-pregnancy body mass index is predictive of a progressive escalation in adverse pregnancy outcomes. J Matern Fetal Neonatal Med. 2012;25:1635–1639.
   PubMed Web of Science ®Google Scholar
• Duntas LH, Orgiazzi J, Brabant G. The interface between thyroid and diabetes mellitus. Clin Endocrinol (Oxf). 2011;75:1–9.
   PubMed Web of Science ®Google Scholar
• James PA, Oparil S, Carter BL, et al. evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;2014(311):507–520.
   Web of Science ®Google Scholar
• Weber-Schoendorfer C, Hannemann D, Meister R, et al. The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study. Reprod Toxicol. 2008;26:24–30.
   PubMed Web of Science ®Google Scholar
• Magee LA, Study Group CHIPS, von Dadelszen P, et al. Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial. BJOG. 2016;123:1143–1151.
   PubMed Web of Science ®Google Scholar
• ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 2002;77:67–75.
   PubMed Web of Science ®Google Scholar
• von Dadelszen P, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: an updated metaregression analysis. J Obstet Gynaecol Can. 2002;24:941–945.
   PubMedGoogle Scholar
• Firoz T, Magee LA, MacDonell K, et al. Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review. BJOG. 2014;121:1210–1218.
   PubMed Web of Science ®Google Scholar
• Sibai BM, Grossman RA, Grossman HG. Effects of diuretics on plasma volume in pregnancies with long-term hypertension. Am J Obstet Gynecol. 1984;150:831–835.
   PubMed Web of Science ®Google Scholar
• Butters L, Kennedy S, Rubin PC. Atenolol in essential hypertension during pregnancy. BMJ. 1990;301:587–589.
   PubMed Web of Science ®Google Scholar
• Rothberger S, Carr D, Brateng D, et al. Pharmacodynamics of clonidine therapy in pregnancy: a heterogeneous maternal response impacts fetal growth. Am J Hypertens. 2010;23:1234–1240.
   PubMed Web of Science ®Google Scholar
• Rossing K, Jacobsen P, Hommel E, et al. Pregnancy and progression of diabetic nephropathy. Diabetologia. 2002;45:36–41.
   PubMed Web of Science ®Google Scholar
• Gordon M, Landon MB, Samuels P, et al. Perinatal outcome and long-term follow-up associated with modern management of diabetic nephropathy. Obstet Gynecol. 1996;87:401–409.
   PubMed Web of Science ®Google Scholar
• Davison JM, Noble MC. Serial changes in 24 hour creatinine clearance during normal menstrual cycles and the first trimester of pregnancy. Br J Obstet Gynaecol. 1981;88:10–17.
   PubMedGoogle Scholar
• Biesenbach G, Stöger H, Zazgornik J. Influence of pregnancy on progression of diabetic nephropathy and subsequent requirement of renal replacement therapy in female type I diabetic patients with impaired renal function. Nephrol Dial Transplant. 1992;7:105–109.
   PubMed Web of Science ®Google Scholar
• Klein BE, Moss SE, Klein R. Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care. 1990;13:34–40.
   PubMed Web of Science ®Google Scholar
• Diabetes Control and Complications Trial Research Group. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The diabetes control and complications trial research group. Diabetes Care. 2000;23:1084–1091.
   PubMed Web of Science ®Google Scholar
• Chew EY, Mills JL, Metzger BE, et al. Metabolic control and progression of retinopathy. The diabetes in early pregnancy study. National Institute of Child Health and Human Development Diabetes in early pregnancy study. Diabetes Care. 1995;18:631–637.
   PubMed Web of Science ®Google Scholar
• Smith A, Eccles-Smith J, D’Emden M, et al. Thyroid disorders in pregnancy and postpartum. Aust Prescr. 2017;40:214–219.
   PubMed Web of Science ®Google Scholar
• Alexander EK, Pearce EN, Brent GA, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017;27:315–389.
   PubMed Web of Science ®Google Scholar
• Lazarus JH. Thyroid function in pregnancy. Br Med Bull. 2011;97:137–148.
   PubMed Web of Science ®Google Scholar
• Papanas N, Demetriou M, Maltezos E. A fairy tale of modern insulin therapy in type 1 diabetes. World J Diabetes. 2010;1:109–110.
   PubMedGoogle Scholar
• Farrar D, Tuffnell DJ, West J, et al. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes. Cochrane Database Syst Rev. 2016;6:CD005542.
   Google Scholar
• Mukhopadhyay A, Farrell T, Fraser RB, et al. Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and metaanalysis of randomized, controlled trials. Am J Obstet Gynecol. 2007;197:447–456.
   PubMed Web of Science ®Google Scholar
• Ranasinghe PD, Maruthur NM, Nicholson WK, et al. Comparative effectiveness of continuous subcutaneous insulin infusion using insulin analogs and multiple daily injections in pregnant women with diabetes mellitus: a systematic review and meta-analysis. J Womens Health (Larchmt). 2015;24:237–249.
   PubMed Web of Science ®Google Scholar
• Secher AL, Ringholm L, Andersen HU, et al. The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care. 2013;36:1877–1883.
   PubMed Web of Science ®Google Scholar